Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

COVID-19 doesn't make alopecia areata worse.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Vitiligo is underreported in medical claims and is linked to certain skin types and autoimmune diseases.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Psychological issues with skin problems worsen patients' lives and treatment.

People in palliative care often have skin problems due to their main illness or other health issues, and treatments focus on comfort and quality of life.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Skin diseases can cause psychological issues, and better integration of dermatology and psychiatry is needed to improve patient care.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Obesity significantly affects skin health, causing conditions like acanthosis nigricans and skin tags, and should be considered during skin exams.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Some skin patients have body image issues linked to social difficulties but want psychological help.

Early hair loss may be linked to metabolic syndrome.

PCOS often causes skin issues like excess hair, acne, and hair loss, needing early treatment.